PYZTERLA Trademark

Trademark Overview


On Tuesday, February 28, 2023, a trademark application was filed for PYZTERLA with the United States Patent and Trademark Office. The USPTO has given the PYZTERLA trademark a serial number of 97814957. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 6, 2024. This trademark is owned by Samsung Bioepis Co., LTD.. The PYZTERLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparation...
pyzterla

General Information


Serial Number97814957
Word MarkPYZTERLA
Filing DateTuesday, February 28, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; medicated pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Bioepis Co., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIncheon 21987
KR

Party NameSamsung Bioepis Co., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIncheon 21987
KR

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 3, 2024ASSIGNED TO LIE
Friday, August 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Thursday, June 22, 2023ASSIGNED TO EXAMINER
Monday, March 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 3, 2023NEW APPLICATION ENTERED